Ophthotech Corporation

(OPHT) Trade

By |

Profile

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet-derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also engaged in developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD. All the business activity of the group is functioned through the United States.

Contact Information

Website: www.ophthotechinc.com
Email: kathy.galante@ophthotech.com
Main Phone: +1 212 845-8200
Address: One Penn Plaza
Address 2: 35th Floor, Suite 3520
State: NY
City / Town: New York
Country: USA
Postal Code: 10119

Issuer Information

Exchange: NGS
CEO: Glenn P. Sblendorio
Employees: 41
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.38 $ -0.03 (-2.13%)
Last Price 1.38 Change $ -0.03 Change % -2.13 Tick N/A
Bid 1.34 Bid Size 100.00 Ask 1.85 Ask Size 2,500.00
Open 1.40 High 1.46 Low 1.34 Prev Close 1.41
Last Trade Volume 226,312 52 Wk Hi 4.50 52 Wk Low 1.34
Market Cap 56.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 41,266,671.00 EPS (TTM) -1.41 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 28
Number of Buys 1 14
Number of Sells 1 14
Net Activity 11912 88458
Last 10 Buys Shares
Axel Bolte 1,000
Axel Bolte 1,000
Thomas Dyrberg 1,000
Nicholas G. Galakatos 1,000
Nicholas G. Galakatos 1,000
Axel Bolte 1,000
Last 10 Sell Shares
Glenn P. Sblendorio 1,000
David R. Guyer 1,000
Barbara A. Wood 1,000
Keith Westby 1,000
Barbara A. Wood 1,000
David R. Guyer 1,000
Keith Westby 1,000
Barbara A. Wood 1,000
Glenn P. Sblendorio 1,000
David R. Guyer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/04/18 03/04/18 03/04/18 03/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 3.67 3.67 3.67 3